Cibisatamab is a T cell bispecific antibody designed to simultaneously engage Carcino-Embryonic Antigen (CEA) present on the surface of cancer cells and the CD3 receptor on T cells. This dual binding capability facilitates the targeted destruction of cancer cells exhibiting moderate to high expression of CEA. Primarily utilized in the study of colorectal cancer, Cibisatamab is instrumental in advancing research focused on immune-mediated cancer cell eradication.
Cibisatamab is a T cell bispecific antibody designed to simultaneously engage Carcino-Embryonic Antigen (CEA) present on the surface of cancer cells and the CD3 receptor on T cells. This dual binding capability facilitates the targeted destruction of cancer cells exhibiting moderate to high expression of CEA. Primarily utilized in the study of colorectal cancer, Cibisatamab is instrumental in advancing research focused on immune-mediated cancer cell eradication.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
